These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1559410)

  • 1. Role of liver in pathophysiology of NIDDM.
    Consoli A
    Diabetes Care; 1992 Mar; 15(3):430-41. PubMed ID: 1559410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.
    Consoli A; Nurjhan N; Capani F; Gerich J
    Diabetes; 1989 May; 38(5):550-7. PubMed ID: 2653926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.
    Consoli A; Nurjhan N; Reilly JJ; Bier DM; Gerich JE
    J Clin Invest; 1990 Dec; 86(6):2038-45. PubMed ID: 2254458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.
    Jenssen T; Nurjhan N; Consoli A; Gerich JE
    J Clin Invest; 1990 Aug; 86(2):489-97. PubMed ID: 2200805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.
    Nurjhan N; Consoli A; Gerich J
    J Clin Invest; 1992 Jan; 89(1):169-75. PubMed ID: 1729269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.
    Firth RG; Bell PM; Marsh HM; Hansen I; Rizza RA
    J Clin Invest; 1986 May; 77(5):1525-32. PubMed ID: 3517067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.
    Mitrakou A; Kelley D; Veneman T; Jenssen T; Pangburn T; Reilly J; Gerich J
    Diabetes; 1990 Nov; 39(11):1381-90. PubMed ID: 2121568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus.
    Tappy L
    Diabete Metab; 1995 Oct; 21(4):233-40. PubMed ID: 8529757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus.
    Kelley D; Mokan M; Veneman T
    Metabolism; 1994 Dec; 43(12):1549-57. PubMed ID: 7990710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.
    Puhakainen I; Koivisto VA; Yki-Järvinen H
    J Clin Endocrinol Metab; 1992 Sep; 75(3):789-94. PubMed ID: 1517368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splanchnic regulation of glucose production.
    Wahren J; Ekberg K
    Annu Rev Nutr; 2007; 27():329-45. PubMed ID: 17465853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects.
    Paquot N; Schneiter P; Jéquier E; Gaillard R; Lefèbvre PJ; Scheen A; Tappy L
    Diabetologia; 1996 May; 39(5):580-6. PubMed ID: 8739918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM.
    Diraison F; Large V; Brunengraber H; Beylot M
    Diabetologia; 1998 Feb; 41(2):212-20. PubMed ID: 9498656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.
    Wright KS; Beck-Nielsen H; Kolterman OG; Mandarino LJ
    Diabetes; 1988 Apr; 37(4):436-40. PubMed ID: 2837418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.
    Campbell PJ; Mandarino LJ; Gerich JE
    Metabolism; 1988 Jan; 37(1):15-21. PubMed ID: 3275857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM.
    Perriello G; Pampanelli S; Del Sindaco P; Lalli C; Ciofetta M; Volpi E; Santeusanio F; Brunetti P; Bolli GB
    Diabetes; 1997 Jun; 46(6):1010-6. PubMed ID: 9166673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
    Porte D; Kahn SE
    Am J Med; 1991 Jun; 90(6A):8S-14S. PubMed ID: 1872310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
    Kelley DE; Simoneau JA
    J Clin Invest; 1994 Dec; 94(6):2349-56. PubMed ID: 7989591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.